BioForm Medical files for $115 million IPO

WASHINGTON, Aug 20 (Reuters) - BioForm Medical Inc, a medical aesthetics company, said on Monday it was planning an initial public offering of as much as $115 million in common stock.

JPMorgan, Piper Jaffray, CIBC World Markets and Jefferies & Company will underwrite the IPO, according to a preliminary offering document filed with the U.S. Securities and Exchange Commission.

The San Mateo, California-based company is seeking a Nasdaq listing under the symbol "BFRM." (Reporting by John Poirier)